Senores Pharmaceuticals Limited has informed the Exchange regarding Notice of the Eighth (8th) Annual General Meeting to be held on September 18, 2025 at 11:30 AM (IST) through VC/OAVM
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has issued the notice for its 8th AGM scheduled for Thursday, September 18, 2025 at 11:30 AM (IST), to be held through Video Conferencing (VC)/OAVM only. Ordinary business includes adoption of the audited standalone and consolidated financial statements for FY ended March 31, 2025, and re-appointment of Mr. Chetan Bipinchandra Shah (Whole Time Director & COO) and Mr. Hemanshu Nitinchandra Pandya (Non-Executive Director), both retiring by rotation. Special business covers revision of remuneration for Managing Director Swapnil Shah and Whole-Time Director Chetan Shah, effective April 1, 2025, along with appointment of M/s. Mukesh H. Shah & Co. as Secretarial Auditors for a 5-year term from FY 2025-26 to FY 2029-30. Remote e-voting window is September 15, 2025 (9:00 AM) to September 17, 2025 (5:00 PM), with the cut-off date for e-voting eligibility set as September 11, 2025.
This is a routine AGM notice, but the special resolution seeking a revision in remuneration of the Managing Director and Whole-Time Director may attract shareholder attention and require voting approval. Retail investors should note the key dates to participate in remote e-voting and review the resolutions, especially the auditor appointment and executive pay revisions, before the September 17 deadline.